Fibrosis  >>  sofosbuvir/velpatasvir  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sofosbuvir/velpatasvir / Generic mfg.
ASTRAL-4, NCT02201901: Sofosbuvir/Velpatasvir Fixed-Dose Combination in Adults With Chronic HCV Infection and Child-Pugh Class B Cirrhosis

Checkmark ASTRAL-1, 2, 3 & 4 studies
Sep 2015 - Sep 2015: ASTRAL-1, 2, 3 & 4 studies
Completed
3
268
US
SOF/VEL, GS-7977/GS-5816, Epclusa®, RBV
Gilead Sciences
Hepatitis C Virus Infection
08/15
11/15
NCT02996682: Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

Completed
3
102
Japan
SOF/VEL, Epclusa®, RBV, Rebetol®
Gilead Sciences
Hepatitis C Virus Infection
02/18
05/18

Download Options